First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

7 Downloads (Pure)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{92ac3b88cae742d9b729cc1af8283a9b,

title = "First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis",

author = "Marscha Holleman and {van Tinteren}, H and HJM Groen and Maiwenn Al and {Uyl - de Groot}, Carin",

year = "2019",

doi = "10.2147/ott.S189438",

language = "English",

volume = "12",

pages = "1413--1421",

journal = "OncoTargets and Therapy",

issn = "1178-6930",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

AU - Holleman, Marscha

AU - van Tinteren, H

AU - Groen, HJM

AU - Al, Maiwenn

AU - Uyl - de Groot, Carin

PY - 2019

Y1 - 2019

U2 - 10.2147/ott.S189438

DO - 10.2147/ott.S189438

M3 - Article

SN - 1178-6930

VL - 12

SP - 1413

EP - 1421

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

ER -